LEGUBETI Drug Patent Profile
✉ Email this page to a colleague
When do Legubeti patents expire, and when can generic versions of Legubeti launch?
Legubeti is a drug marketed by Galephar and is included in one NDA.
The generic ingredient in LEGUBETI is acetylcysteine lysine. There are three drug master file entries for this compound. Additional details are available on the acetylcysteine lysine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LEGUBETI?
- What are the global sales for LEGUBETI?
- What is Average Wholesale Price for LEGUBETI?
Summary for LEGUBETI
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Patent Applications: | 122 |
DailyMed Link: | LEGUBETI at DailyMed |
![LEGUBETI drug patent expirations Drug patent expirations by year for LEGUBETI](/p/graph/s/t/LEGUBETI-patent-expirations.png)
US Patents and Regulatory Information for LEGUBETI
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Galephar | LEGUBETI | acetylcysteine lysine | FOR SOLUTION;ORAL | 215040-002 | Feb 13, 2024 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Galephar | LEGUBETI | acetylcysteine lysine | FOR SOLUTION;ORAL | 215040-001 | Feb 13, 2024 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |